Skip to main content
SeouLinBioscienceCO.,LTD. logo

SeouLinBioscienceCO.,LTD. — Investor Relations & Filings

Ticker · 038070 ISIN · KR7038070009 KO Professional, scientific and technical activities
Open in API
Filings indexed 209 across all filing types
Latest filing 2025-04-01 Director's Dealing
Country KR South Korea
Listing KO 038070

About SeouLinBioscienceCO.,LTD.

SeouLin Bioscience is a total solutions provider for the life sciences and healthcare sectors, specializing in bio-research and production. Established in 1984, the company supplies a comprehensive range of research reagents, laboratory equipment, and materials. It also develops and manufactures specialized products, including Hypochlorous Acid (HOCl) sterilization water generators, DNA chip scanners, and diagnostic DNA kits. The company's research and development activities focus on creating novel diagnostic solutions, such as field kits for detecting marine viruses and pathogens related to food safety. SeouLin Bioscience aims to deliver integrated solutions that support scientific discovery and bioproduction processes.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a standard regulatory disclosure for insider transactions or changes in share ownership by company directors and executives. Based on the provided categories, this aligns with 'Director's Dealing' (DIRS), which covers personal share transactions and ownership reports by company directors and executives.
2025-04-01 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share ownership changes of an executive (Ahn Kwang-Ki) at Seoulin Bioscience. This type of filing is a standard regulatory requirement for reporting insider transactions or changes in holdings by company directors/executives, which corresponds to the 'Director's Dealing' category.
2025-04-01 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official report of the results of a General Meeting of Shareholders (AGM) for Seorin Bio. It details the approval of financial statements, dividend resolutions, and the election of directors and auditors. This falls directly under the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), as it provides the official outcome of shareholder votes at the meeting.
2025-03-26 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed with the Korean Exchange (KRX). It contains the auditor's opinion (적정 - unqualified), financial statements (assets, liabilities, equity, profit/loss), and details regarding the external auditor (Samduk Accounting Corp). This is a standard regulatory filing in Korea that provides the results of the annual audit, which falls under the 'Audit Report / Information' category. FY 2024
2025-03-18 Korean
[첨부추가]사업보고서 (2024.12)
Audit Report / Information Classification · 1% confidence The document is a 'Consolidated Audit Report' (연결감사보고서) for Seorin Bioscience, covering the fiscal years 2023 and 2024. It includes the independent auditor's report, consolidated financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and notes to the financial statements. This is a formal, comprehensive financial audit document, not an earnings release or a report publication announcement. Therefore, it is classified as an Audit Report (AR). FY 2024
2025-03-18 Korean
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 1% confidence The document is a regulatory filing from the Korean stock market (DART system) regarding a correction (정정신고) to a previously filed report on 'Changes in Sales or Profit/Loss Structure of 30% or more'. It provides updated financial figures (Net Income, Assets, Liabilities, Equity) due to audit adjustments. Since this is a specific regulatory disclosure regarding financial performance updates and corrections, it falls under the 'Regulatory Filings' category as it does not fit into a full Annual Report or a simple announcement of a report. FY 2024
2025-03-10 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.